AS 921
Alternative Names: AS-921Latest Information Update: 23 Apr 2024
At a glance
- Originator Amyloid Solution
- Class Antidementias; Small molecules
- Mechanism of Action Ghrelin receptor agonists; Sphingomyelin phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 12 Apr 2024 Early research in Alzheimer's disease in South Korea (unspecified route) (Amyloid Solution Pipeline, April 2024)